# Investigation of Intraocular Pressure (IOP) Reduction Efficacy of Travoprost Ophthalmic Solution in Patients With Normal Tension Glaucoma

> **NCT01995136** · PHASE4 · COMPLETED · sponsor: **Alcon Research** · enrollment: 32 (actual)

## Conditions studied

- Normal Tension Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** Travoprost Ophthalmic Solution 0.004%

## Key facts

- **NCT ID:** NCT01995136
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2015-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01995136

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01995136, "Investigation of Intraocular Pressure (IOP) Reduction Efficacy of Travoprost Ophthalmic Solution in Patients With Normal Tension Glaucoma". Retrieved via AI Analytics 2026-06-06 from https://api.ai-analytics.org/clinical/NCT01995136. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*